Cached score snapshot

US.SOLV · Solventum

110分制 47.8/110;5D動能v2 8/50;排序分 55.8/160

Ranking score 55.8/160
Main score 47.8/110
5D momentum v2 8/50
Rank #363
Setup grade F 23.4

Score breakdown

避免

Elevated twelvedata

Score and price trend

F 23.4 Elevated risk

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

0 40 80 110 Score 04-10 07-14 07-27 08-06 08-18 $62.96$78.70$94.44 Price Projection date
Historical projection
Model Median P25/P75 歷史相似情境上漲比例 Down5 Actual / compare
Rolling DOE best · score 3.07 · anchors 120 +1.00% -1.34% / +3.49% 61.2% 3.2% Actual +0.55% · vs median -0.45% · inside 25-75 band
30D observation +8.07% -1.94% / +15.53% 70.6% 18.6% Actual outcome pending · 1 / 30 bars observed
Historical projection 10D n=160 +1.01% -1.61% / +3.67% 63.1% 1.9% Actual outcome pending · 1 / 10 bars observed

歷史情境統計基於已存檔相似 setup;圖中投影中位線為統計中位數的線性插值展示,並非價格路徑預測或買賣建議。

2026-04-10 → 2026-08-18 · 438 archived points · 2 Improving turn signal · 10 Deteriorating signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 55.8
Display grade 避免
Model version cursor_18_27_news_v2_160
Main score 47.8/110 (避免)
5D momentum v2 8/50 (弱)
Score with momentum v2 55.8/160 (低排序)
Risk level Elevated

Audit trace

Full calculation detail

Calculation detail · 8 sections

Market inputs

Bar count 60
ma20 77.526
ma50 75.186
close 76.28
prevClose 77.94
avgVolume20 1507359
volumeRatio 0.82
changePercent -2.13

Metrics snapshot

close 76.28
volume 1239670
changePercent -2.13

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 47.8/110
Main rating 避免
5D momentum v2 8/50
Score with momentum v2 55.8/160
Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 3.2/5 · 一般

Dimension score 3.2/5
Dimension grade 一般

Sub-items

pbPoints 0.4
pePoints 0.4
epsPoints 0
roePoints 0.75
debtPoints 0.4
marginPoints 0.4
turnoverUsdM 94.562
volumePoints 0.5
revenuePoints 0
dividendPoints 0
marketCapPoints 0.4

資金流 — 8.4/20 · 較差

Dimension score 8.4/20
Dimension grade 較差

Sub-items

cmfPoints 0.8
mfiPoints 0.8
obvPoints 4
vwapPoints 0.8

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL
symbol US.SOLV
message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.
optional true
holderCount n/a
holderPoints 2
top10ShareRatio n/a
concentrationPenalty 0
institutionPoints 2

市場環境 — 8.4/15 · 較差

Dimension score 8.4/15
Dimension grade 較差

Sub-items

vix

score 2.4

details

source twelvedata+fred
vixClose 15.57

trend

score 2.4

details

qqq

ma20 720.433
ma50 711.664
name QQQ
close 709.43
points 0.4

spy

ma20 741.2935
ma50 739.0122
name SPY
close 747.71
points 2
source twelvedata+fred
atrPct 3.016
atrPoints 2
cciPoints 1.6
vixPoints 2.4
marketTrendPoints 2.4

催化劑 — 2/20 · 較差

Dimension score 2/20
Dimension grade 較差

Sub-items

catalyst

score 2

details

source finnhub_news_keyword_model
articleCount 6
catalystCount 0
catalystPoints 2

風險管理 — 6.3/10 · 一般

Dimension score 6.3/10
Dimension grade 一般

Sub-items

position

score 1.1

details

atrPct 3.016
turnoverUsdM 94.562
liquidityPoints 0.4
volatilityPoints 0.7
rrPoints 1.4

stopLevels

symbol US.SOLV
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 71.6788

strength_details

ma_score 1.5
atr_score 1
rsi_score 1
macd_score 1.5
volume_score 1
market_adjustment 1
risk_reward_ratio 1
stop_loss_percent 6
take_profit_price 80.094
target_multiplier 1.6
technical_strength 1.22
take_profit_percent 5
positionPoints 1.1
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 6.032
diversificationPoints 2

技術信號 — 17.5/30 · 較差

Dimension score 17.5/30
Dimension grade 較差

Sub-items

bbPoints 2.4
adxPoints 3
sarPoints 2.4
vcpPoints 1
macdPoints 2.4

vcpPayload

vcp_pass false
vcp_score 1
vcp_reason 跌縮量(近10日4日);站上MA50;Ready=N;Confirm=N

vcp_metrics

up_days 5
vol_ref 2024920
down_days 4
vcp_ready false
above_ma50 true
avg_vol_10 1463700
avg_vol_20 1531720
avg_vol_30 2024920
range_pct_10 0.0991
range_pct_20 0.1361
range_pct_30 0.1361
up_expand_ok false
lookback_used 59
near_20d_high false
contraction_ok false
down_shrink_ok true
up_expand_days 1
breakout_20d_ok false
vol_ratio_10_30 0.7228
dist_to_20d_high 0.0856
down_shrink_days 4
breakout_level_20d 83.42
vcp_breakout_confirm false
contraction_ratio_10_30 0.7283
vcp_name_en Volatility Contraction Pattern
vcp_name_zh 波動收縮形態
vol_contraction false
kdjAdxPoints 0.5
rsiKdjPoints 2.4
volumeWeight 2
maCrossPoints 1.6
shortRsiPoints 0
shortMacdPoints 0.4
volConfirmPoints 0.6
volumePointsTechnical 0.8

情緒分析 — 2/10 · 較差

Dimension score 2/10
Dimension grade 較差

Sub-items

sentiment

score 2

details

source finnhub_news_keyword_model
articleCount 6
negativeHits 0
positiveHits 0
sentimentScoreRaw 0

sentimentData

raw {"id":140691748,"url":"https://finnhub.io/api/news?id=ed72fe9fb77ea65d160cc73dea4087e09468637a7a3d2d11625d60da5d2d9a79","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"The healthcare sector has had a mixed year, yet Solventum shareholders might feel as though they drew the short straw.","category":"company","datetime":1782109556,"headline":"Solventum Stock: Is SOLV Underperforming the Healthcare Sector?"}, {"id":140626854,"url":"https://finnhub.io/api/news?id=24c37e0305b2a1b47a29651c2f0ce19541fc89152d080f5d48968d5219fcfee9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Solventum (SOLV) has started to attract more attention after its recent trading performance, with the stock up about 6% over the past month and roughly 18% over the past three months. See our latest analysis for Solventum. Zooming out, Solventum’s share price is now at US$78.87, with a 1 day share price return slightly down at 0.44%, while the 1 month share price return of about 6% and 3 month share price return of roughly 18% suggest momentum has been building. This comes even as the year to...","category":"company","datetime":1781345407,"headline":"Solventum (SOLV) Stock Valuation Gap Examined After Recent Momentum Gains"}, {"id":140624909,"url":"https://finnhub.io/api/news?id=bda0bcb59dda336ce1abdee63e5eb129c6f1df366fec9e28a009a9c01d9ef876","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Solventum’s latest analyst update keeps the model fair value unchanged at US$82.15 per share, which is now being weighed against external price targets such as the bullish US$94 level. That gap mirrors the split in recent research, with some firms leaning into the post spin story and others trimming targets as they focus on execution risk and EBIT compression. As you read on, you will see how to track these shifting views and what signals to watch as the narrative around Solventum...","category":"company","datetime":1781309688,"headline":"Solventum (SOLV) Stock Sees Split Analyst Revisions After Post Spin Margin Debate"}, {"id":140613133,"url":"https://finnhub.io/api/news?id=fa7dc8445299911bf16502caaeab45d89c5c4cbbc69b958e2ee1a72a63a007d6","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Is SOLV a good stock to buy? We came across a bullish thesis on Solventum Corporation on r/ValueInvesting by raytoei. In this article, we will summarize the bulls’ thesis on SOLV. Solventum Corporation’s share was trading at $82.46 as of June 9th. SOLV’s trailing and forward P/E were 10.09 and 12.58 respectively according to Yahoo Finance. Solventum […]","category":"company","datetime":1781208796,"headline":"Is Solventum Corporation (SOLV) A Good Stock To Buy Now?"}, {"id":140566317,"url":"https://finnhub.io/api/news?id=3b6fc16b6d19a8fd349161587661a664532f9c86aa7e6225bdf22f80a96ef57b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including Solventum (NYSE:SOLV) and its peers.","category":"company","datetime":1780907390,"headline":"Q1 Earnings Roundup: Solventum (NYSE:SOLV) And The Rest Of The Surgical Equipment & Consumables - Diversified Segment"}, {"id":140563924,"url":"https://finnhub.io/api/news?id=6f2972e3ab42ef5f7fad1508fd81ca3b91b6fd318faba1d5b334f07cbeb958ec","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"In May 2024, a stockholder class action in Delaware challenged aspects of Solventum’s advance notice and nomination by-laws, which the company later amended before resolving the case as moot and agreeing to pay US$120,000 in attorneys’ fees without admitting wrongdoing. This outcome highlights how investor pressure over governance terms can prompt Solventum to adjust its corporate by-laws while balancing legal risk and cost. We’ll now examine how concerns about AI-driven disruption in...","category":"company","datetime":1780877732,"headline":"Is Solventum’s (SOLV) Governance Tweaks Hinting At How It Will Navigate AI Disruption?"}
raw_source {"id":140828483,"url":"https://finnhub.io/api/news?id=bf8918978d2cd7b2272874c0d7ca747df00337f4633eb015af598f6a2f78f1b7","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.","category":"company","datetime":1783417092,"headline":"2 S&P 500 Stocks to Own for Decades and 1 We Question"}, {"id":140760996,"url":"https://finnhub.io/api/news?id=4523f9cbba64f3a8f17f7175ba34ca7ba37a96c1f5b2c836a77206be1d4d4874","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with competition, ranging from giants with vast resources to agile upstarts eager to disrupt the status quo.","category":"company","datetime":1782730695,"headline":"3 Mid-Cap Stocks We Steer Clear Of"}, {"id":140723949,"url":"https://finnhub.io/api/news?id=d2677b2d8b96dbcb42b1cc6213f453f5d03b8dbd6f7add01322411980e68b907","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have realized strong financial performance, and over the past six months, the industry’s 7.6% return has closely followed the S&P 500.","category":"company","datetime":1782384590,"headline":"3 Healthcare Stocks with Questionable Fundamentals"}, {"id":140691146,"url":"https://finnhub.io/api/news?id=843562ed61fee58039a285e36f019315c1d1a32065cd26057a37a4840411af50","image":"https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp","source":"ChartMill","related":"SOLV","summary":"Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.","category":"company","datetime":1782131700,"headline":"What's going on in today's pre-market session: S&P500 movers"}, {"id":140691748,"url":"https://finnhub.io/api/news?id=ed72fe9fb77ea65d160cc73dea4087e09468637a7a3d2d11625d60da5d2d9a79","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"The healthcare sector has had a mixed year, yet Solventum shareholders might feel as though they drew the short straw.","category":"company","datetime":1782109556,"headline":"Solventum Stock: Is SOLV Underperforming the Healthcare Sector?"}, {"id":140648098,"url":"https://finnhub.io/api/news?id=f1c2fc41edbb5fcda3d2a241cdfa0e7096774507d961e843dde257a6c0ff9122","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Cooper Companies has lagged behind the healthcare sector over the past year, and analysts remain moderately bullish about its prospects.","category":"company","datetime":1781611647,"headline":"Cooper Companies Stock: Is COO Underperforming the Healthcare Sector?"}, {"id":140626854,"url":"https://finnhub.io/api/news?id=24c37e0305b2a1b47a29651c2f0ce19541fc89152d080f5d48968d5219fcfee9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Solventum (SOLV) has started to attract more attention after its recent trading performance, with the stock up about 6% over the past month and roughly 18% over the past three months. See our latest analysis for Solventum. Zooming out, Solventum’s share price is now at US$78.87, with a 1 day share price return slightly down at 0.44%, while the 1 month share price return of about 6% and 3 month share price return of roughly 18% suggest momentum has been building. This comes even as the year to...","category":"company","datetime":1781345407,"headline":"Solventum (SOLV) Stock Valuation Gap Examined After Recent Momentum Gains"}, {"id":140624909,"url":"https://finnhub.io/api/news?id=bda0bcb59dda336ce1abdee63e5eb129c6f1df366fec9e28a009a9c01d9ef876","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Solventum’s latest analyst update keeps the model fair value unchanged at US$82.15 per share, which is now being weighed against external price targets such as the bullish US$94 level. That gap mirrors the split in recent research, with some firms leaning into the post spin story and others trimming targets as they focus on execution risk and EBIT compression. As you read on, you will see how to track these shifting views and what signals to watch as the narrative around Solventum...","category":"company","datetime":1781309688,"headline":"Solventum (SOLV) Stock Sees Split Analyst Revisions After Post Spin Margin Debate"}, {"id":140613133,"url":"https://finnhub.io/api/news?id=fa7dc8445299911bf16502caaeab45d89c5c4cbbc69b958e2ee1a72a63a007d6","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Is SOLV a good stock to buy? We came across a bullish thesis on Solventum Corporation on r/ValueInvesting by raytoei. In this article, we will summarize the bulls’ thesis on SOLV. Solventum Corporation’s share was trading at $82.46 as of June 9th. SOLV’s trailing and forward P/E were 10.09 and 12.58 respectively according to Yahoo Finance. Solventum […]","category":"company","datetime":1781208796,"headline":"Is Solventum Corporation (SOLV) A Good Stock To Buy Now?"}, {"id":140607998,"url":"https://finnhub.io/api/news?id=f8205004c86b95abe8752861730a9033111a1e4234413223e5fb2f5ce54b435c","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"SOLV","summary":"Curious about the S&P500 stocks that are in motion on Thursday? Join us as we explore the top movers within the S&P500 index during today's session.","category":"company","datetime":1781195700,"headline":"What's going on in today's session: S&P500 movers"}, {"id":140578957,"url":"https://finnhub.io/api/news?id=cd6c2cb33bc5a62d1db12d5f2225d4adc5bb346ed27073af554cbee5deed4228","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.","category":"company","datetime":1780995734,"headline":"1 Profitable Stock with Exciting Potential and 2 That Underwhelm"}, {"id":140572133,"url":"https://finnhub.io/api/news?id=1e43f0c3315f080a701688446336ea4429c270f1692c22c5e883bace10cb6406","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"SOLV","summary":"Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session.","category":"company","datetime":1780945500,"headline":"Top S&P500 movers in Monday's session"}, {"id":140572721,"url":"https://finnhub.io/api/news?id=ac249af88351922bc21ddf94a8632793da27afa5665cbebd4c3bcff409a36f4b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"SOLV heads into 2026 balancing AI coding growth, cost savings, tariff pressure and a potential 2027 margin risk tied to its 3M supply deal.","category":"company","datetime":1780939920,"headline":"Solventum Trends for 2026: AI Coding, Tariffs, and Margins"}, {"id":140566317,"url":"https://finnhub.io/api/news?id=3b6fc16b6d19a8fd349161587661a664532f9c86aa7e6225bdf22f80a96ef57b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including Solventum (NYSE:SOLV) and its peers.","category":"company","datetime":1780907390,"headline":"Q1 Earnings Roundup: Solventum (NYSE:SOLV) And The Rest Of The Surgical Equipment & Consumables - Diversified Segment"}, {"id":140563924,"url":"https://finnhub.io/api/news?id=6f2972e3ab42ef5f7fad1508fd81ca3b91b6fd318faba1d5b334f07cbeb958ec","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"In May 2024, a stockholder class action in Delaware challenged aspects of Solventum’s advance notice and nomination by-laws, which the company later amended before resolving the case as moot and agreeing to pay US$120,000 in attorneys’ fees without admitting wrongdoing. This outcome highlights how investor pressure over governance terms can prompt Solventum to adjust its corporate by-laws while balancing legal risk and cost. We’ll now examine how concerns about AI-driven disruption in...","category":"company","datetime":1780877732,"headline":"Is Solventum’s (SOLV) Governance Tweaks Hinting At How It Will Navigate AI Disruption?"}
data_source finnhub_news_keyword_model
article_count 6
negative_hits 0
positive_hits 0
recomputed_at_score true
sentiment_score_raw 0
source_article_count 15
discarded_article_count 9
sentimentPoints 2

Dimension contribution

Dimension Raw Max Norm % Contrib
基本面 3.2 5/110 64% 3.2
資金流 8.4 20/110 42% 8.4
市場環境 8.4 15/110 56% 8.4
催化劑 2 20/110 10% 2
風險管理 6.3 10/110 63% 6.3
技術信號 17.5 30/110 58.33% 17.5
情緒分析 2 10/110 20% 2

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 8/50
ret_5d -0.0251
max_score 50
max_total 50
raw_total 8
vcp_bonus 0
vol_ratio 0.8093
ret_points 0
vol_points 0
range_ratio 1.6299
volat_points 4
day_range_pct 0.0484
model_version cursor_18_27_news_v2_160
available_bars 30
breakout_points 0
partial_history false
pullback_points 4
breakout_vol_bonus 0
first_breakout_20d false
return_window_days 5
first_breakout_bonus 0
breakout_quality_points 0

Risk management

level Elevated
reason risk management score >= 5/10

position

score 1.1

details

atrPct 3.016
turnoverUsdM 94.562
liquidityPoints 0.4
volatilityPoints 0.7
rrPoints 1.4

stopLevels

symbol US.SOLV
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 71.6788

strength_details

ma_score 1.5
atr_score 1
rsi_score 1
macd_score 1.5
volume_score 1
market_adjustment 1
risk_reward_ratio 1
stop_loss_percent 6
take_profit_price 80.094
target_multiplier 1.6
technical_strength 1.22
take_profit_percent 5
positionPoints 1.1
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 6.032
diversificationPoints 2

Calculation audit log

基本面分析總分: 3.2/5分
資金流分析總分: 8.4/20分
市場環境分析總分: 8.4/15分
催化劑分析: 2/20分
風險管理總分: 6.3/10分
技術信號分析總分: 17.5/30分
情緒分析: 2/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx
value 92.86
atr
atr 2.3006
rule ATR / current price; lower volatility scores higher
score 4
atr_pct 3.02
cci
rule Cursor_18.24 CCI bands
level 弱勢
score 4
value -25.12
cmf
rule Cursor_18.24 CMF bands
level 派發
score 2
value -0.0847
kdj
d 57.1
j 46.2
k 53.47
rule Cursor_18.24 K/D cross
score 0
signal 死叉
mfi
rule Cursor_18.24 MFI bands
level 超賣或超買風險
score 2
value 36.99
obv
rule Cursor_18.24 recent_slope vs previous_slope
score 10
trend 強流入
value 2230230
recentSlope 16253
previousSlope -439190
rsi
value 48.14
sar
rule Cursor_18.24 Parabolic SAR
score 8
trend 上升
value 74.7744
position SAR喺價下
distancePct 1.97
previousTrend 上升
ma50
value 75.186
macd
macd 0.4909
trend 中性偏多
signal 0.6527
histogram -0.1618
vwap
rule Cursor_18.24 VWAP 20D consecutive close
score 2
value 77.629
position <VWAP
consecutiveAbove 0
volume
rule Cursor_18.24 volume ratio
level 無力
ratio 0.82
score 4
avgVolume 1507359
currentVolume 1239670
derived
ma20 77.526
ma50 75.186
prevClose 77.94
avgVolume10 1386787
avgVolume20 1507359
changePercent -2.13
avgVolumeForScore 1507359
ma_cross
ma20 77.526
ma50 75.186
rule Cursor_18.24 MA20/MA50 cross
cross 多頭
score 4
prevMa20 77.7625
prevMa50 75.0396
spreadPct 3.11
isVolumeBreakout false
bollinger
lower 73.1334
upper 81.9186
position 中間
rsi_short
value 21.24
macd_short
macd 0
trend 中性
signal 0
histogram 0
volume_ratio
ratio 0.82

Raw calculation JSON

{
  "risk": {
    "level": "Elevated",
    "reason": "risk management score >= 5/10",
    "position": {
      "score": 1.1,
      "details": {
        "atrPct": 3.0159937073938123,
        "turnoverUsdM": 94.5620276,
        "liquidityPoints": 0.4,
        "volatilityPoints": 0.7
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.SOLV",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 71.6788,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 1,
        "rsi_score": 1,
        "macd_score": 1.5,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 6,
      "take_profit_price": 80.094,
      "target_multiplier": 1.6,
      "technical_strength": 1.22,
      "take_profit_percent": 5
    },
    "positionPoints": 1.1,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 6.031987414787625,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 55.8,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 47.8,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 8
  },
  "market": {
    "ma20": 77.526,
    "ma50": 75.186,
    "close": 76.28,
    "prevClose": 77.94,
    "avgVolume20": 1507359,
    "volumeRatio": 0.82,
    "changePercent": -2.13
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 8,
    "details": {
      "ret_5d": -0.025051124744376208,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 8,
      "vcp_bonus": 0,
      "vol_ratio": 0.8093319927924164,
      "ret_points": 0,
      "vol_points": 0,
      "range_ratio": 1.629926116769576,
      "volat_points": 4,
      "day_range_pct": 0.04837441006816987,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 4,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 55.8,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.2,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 64,
        "contribution": 3.2
      },
      {
        "raw": 8.4,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 42,
        "contribution": 8.4
      },
      {
        "raw": 8.4,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 56,
        "contribution": 8.4
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 6.3,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 63,
        "contribution": 6.3
      },
      {
        "raw": 17.5,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 58.33,
        "contribution": 17.5
      },
      {
        "raw": 2,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 20,
        "contribution": 2
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "避免",
    "result": 47.8,
    "details": [
      "基本面分析總分: 3.2/5分",
      "資金流分析總分: 8.4/20分",
      "市場環境分析總分: 8.4/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 6.3/10分",
      "技術信號分析總分: 17.5/30分",
      "情緒分析: 2/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 3.2,
      "資金流": 8.4,
      "市場環境": 8.4,
      "情緒分析": 2,
      "技術信號": 17.5,
      "風險管理": 6.3
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 6,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "一般",
        "items": {
          "pbPoints": 0.4,
          "pePoints": 0.4,
          "epsPoints": 0,
          "roePoints": 0.75,
          "debtPoints": 0.4,
          "marginPoints": 0.4,
          "turnoverUsdM": 94.5620276,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0,
          "marketCapPoints": 0.4
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 0.8,
          "obvPoints": 4,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.SOLV",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 15.57
            }
          },
          "trend": {
            "score": 2.4,
            "details": {
              "qqq": {
                "ma20": 720.4330052000001,
                "ma50": 711.66400144,
                "name": "QQQ",
                "close": 709.42999,
                "points": 0.4
              },
              "spy": {
                "ma20": 741.2935059,
                "ma50": 739.0122021000002,
                "name": "SPY",
                "close": 747.71002,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 3.0159937073938123,
          "atrPoints": 2,
          "cciPoints": 1.6,
          "vixPoints": 2.4,
          "marketTrendPoints": 2.4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 6,
              "negativeHits": 0,
              "positiveHits": 0,
              "sentimentScoreRaw": 0
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 140691748,
                "url": "https://finnhub.io/api/news?id=ed72fe9fb77ea65d160cc73dea4087e09468637a7a3d2d11625d60da5d2d9a79",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "The healthcare sector has had a mixed year, yet Solventum shareholders might feel as though they drew the short straw.",
                "category": "company",
                "datetime": 1782109556,
                "headline": "Solventum Stock: Is SOLV Underperforming the Healthcare Sector?"
              },
              {
                "id": 140626854,
                "url": "https://finnhub.io/api/news?id=24c37e0305b2a1b47a29651c2f0ce19541fc89152d080f5d48968d5219fcfee9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Solventum (SOLV) has started to attract more attention after its recent trading performance, with the stock up about 6% over the past month and roughly 18% over the past three months. See our latest analysis for Solventum. Zooming out, Solventum’s share price is now at US$78.87, with a 1 day share price return slightly down at 0.44%, while the 1 month share price return of about 6% and 3 month share price return of roughly 18% suggest momentum has been building. This comes even as the year to...",
                "category": "company",
                "datetime": 1781345407,
                "headline": "Solventum (SOLV) Stock Valuation Gap Examined After Recent Momentum Gains"
              },
              {
                "id": 140624909,
                "url": "https://finnhub.io/api/news?id=bda0bcb59dda336ce1abdee63e5eb129c6f1df366fec9e28a009a9c01d9ef876",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Solventum’s latest analyst update keeps the model fair value unchanged at US$82.15 per share, which is now being weighed against external price targets such as the bullish US$94 level. That gap mirrors the split in recent research, with some firms leaning into the post spin story and others trimming targets as they focus on execution risk and EBIT compression. As you read on, you will see how to track these shifting views and what signals to watch as the narrative around Solventum...",
                "category": "company",
                "datetime": 1781309688,
                "headline": "Solventum (SOLV) Stock Sees Split Analyst Revisions After Post Spin Margin Debate"
              },
              {
                "id": 140613133,
                "url": "https://finnhub.io/api/news?id=fa7dc8445299911bf16502caaeab45d89c5c4cbbc69b958e2ee1a72a63a007d6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Is SOLV a good stock to buy? We came across a bullish thesis on Solventum Corporation on r/ValueInvesting by raytoei. In this article, we will summarize the bulls’ thesis on SOLV. Solventum Corporation’s share was trading at $82.46 as of June 9th. SOLV’s trailing and forward P/E were 10.09 and 12.58 respectively according to Yahoo Finance. Solventum […]",
                "category": "company",
                "datetime": 1781208796,
                "headline": "Is Solventum Corporation (SOLV) A Good Stock To Buy Now?"
              },
              {
                "id": 140566317,
                "url": "https://finnhub.io/api/news?id=3b6fc16b6d19a8fd349161587661a664532f9c86aa7e6225bdf22f80a96ef57b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including Solventum (NYSE:SOLV) and its peers.",
                "category": "company",
                "datetime": 1780907390,
                "headline": "Q1 Earnings Roundup: Solventum (NYSE:SOLV) And The Rest Of The Surgical Equipment & Consumables - Diversified Segment"
              },
              {
                "id": 140563924,
                "url": "https://finnhub.io/api/news?id=6f2972e3ab42ef5f7fad1508fd81ca3b91b6fd318faba1d5b334f07cbeb958ec",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "In May 2024, a stockholder class action in Delaware challenged aspects of Solventum’s advance notice and nomination by-laws, which the company later amended before resolving the case as moot and agreeing to pay US$120,000 in attorneys’ fees without admitting wrongdoing. This outcome highlights how investor pressure over governance terms can prompt Solventum to adjust its corporate by-laws while balancing legal risk and cost. We’ll now examine how concerns about AI-driven disruption in...",
                "category": "company",
                "datetime": 1780877732,
                "headline": "Is Solventum’s (SOLV) Governance Tweaks Hinting At How It Will Navigate AI Disruption?"
              }
            ],
            "raw_source": [
              {
                "id": 140828483,
                "url": "https://finnhub.io/api/news?id=bf8918978d2cd7b2272874c0d7ca747df00337f4633eb015af598f6a2f78f1b7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.",
                "category": "company",
                "datetime": 1783417092,
                "headline": "2 S&P 500 Stocks to Own for Decades and 1 We Question"
              },
              {
                "id": 140760996,
                "url": "https://finnhub.io/api/news?id=4523f9cbba64f3a8f17f7175ba34ca7ba37a96c1f5b2c836a77206be1d4d4874",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with competition, ranging from giants with vast resources to agile upstarts eager to disrupt the status quo.",
                "category": "company",
                "datetime": 1782730695,
                "headline": "3 Mid-Cap Stocks We Steer Clear Of"
              },
              {
                "id": 140723949,
                "url": "https://finnhub.io/api/news?id=d2677b2d8b96dbcb42b1cc6213f453f5d03b8dbd6f7add01322411980e68b907",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have realized strong financial performance, and over the past six months, the industry’s 7.6% return has closely followed the S&P 500.",
                "category": "company",
                "datetime": 1782384590,
                "headline": "3 Healthcare Stocks with Questionable Fundamentals"
              },
              {
                "id": 140691146,
                "url": "https://finnhub.io/api/news?id=843562ed61fee58039a285e36f019315c1d1a32065cd26057a37a4840411af50",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "SOLV",
                "summary": "Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.",
                "category": "company",
                "datetime": 1782131700,
                "headline": "What's going on in today's pre-market session: S&P500 movers"
              },
              {
                "id": 140691748,
                "url": "https://finnhub.io/api/news?id=ed72fe9fb77ea65d160cc73dea4087e09468637a7a3d2d11625d60da5d2d9a79",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "The healthcare sector has had a mixed year, yet Solventum shareholders might feel as though they drew the short straw.",
                "category": "company",
                "datetime": 1782109556,
                "headline": "Solventum Stock: Is SOLV Underperforming the Healthcare Sector?"
              },
              {
                "id": 140648098,
                "url": "https://finnhub.io/api/news?id=f1c2fc41edbb5fcda3d2a241cdfa0e7096774507d961e843dde257a6c0ff9122",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Cooper Companies has lagged behind the healthcare sector over the past year, and analysts remain moderately bullish about its prospects.",
                "category": "company",
                "datetime": 1781611647,
                "headline": "Cooper Companies Stock: Is COO Underperforming the Healthcare Sector?"
              },
              {
                "id": 140626854,
                "url": "https://finnhub.io/api/news?id=24c37e0305b2a1b47a29651c2f0ce19541fc89152d080f5d48968d5219fcfee9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Solventum (SOLV) has started to attract more attention after its recent trading performance, with the stock up about 6% over the past month and roughly 18% over the past three months. See our latest analysis for Solventum. Zooming out, Solventum’s share price is now at US$78.87, with a 1 day share price return slightly down at 0.44%, while the 1 month share price return of about 6% and 3 month share price return of roughly 18% suggest momentum has been building. This comes even as the year to...",
                "category": "company",
                "datetime": 1781345407,
                "headline": "Solventum (SOLV) Stock Valuation Gap Examined After Recent Momentum Gains"
              },
              {
                "id": 140624909,
                "url": "https://finnhub.io/api/news?id=bda0bcb59dda336ce1abdee63e5eb129c6f1df366fec9e28a009a9c01d9ef876",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Solventum’s latest analyst update keeps the model fair value unchanged at US$82.15 per share, which is now being weighed against external price targets such as the bullish US$94 level. That gap mirrors the split in recent research, with some firms leaning into the post spin story and others trimming targets as they focus on execution risk and EBIT compression. As you read on, you will see how to track these shifting views and what signals to watch as the narrative around Solventum...",
                "category": "company",
                "datetime": 1781309688,
                "headline": "Solventum (SOLV) Stock Sees Split Analyst Revisions After Post Spin Margin Debate"
              },
              {
                "id": 140613133,
                "url": "https://finnhub.io/api/news?id=fa7dc8445299911bf16502caaeab45d89c5c4cbbc69b958e2ee1a72a63a007d6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Is SOLV a good stock to buy? We came across a bullish thesis on Solventum Corporation on r/ValueInvesting by raytoei. In this article, we will summarize the bulls’ thesis on SOLV. Solventum Corporation’s share was trading at $82.46 as of June 9th. SOLV’s trailing and forward P/E were 10.09 and 12.58 respectively according to Yahoo Finance. Solventum […]",
                "category": "company",
                "datetime": 1781208796,
                "headline": "Is Solventum Corporation (SOLV) A Good Stock To Buy Now?"
              },
              {
                "id": 140607998,
                "url": "https://finnhub.io/api/news?id=f8205004c86b95abe8752861730a9033111a1e4234413223e5fb2f5ce54b435c",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "SOLV",
                "summary": "Curious about the S&P500 stocks that are in motion on Thursday? Join us as we explore the top movers within the S&P500 index during today's session.",
                "category": "company",
                "datetime": 1781195700,
                "headline": "What's going on in today's session: S&P500 movers"
              },
              {
                "id": 140578957,
                "url": "https://finnhub.io/api/news?id=cd6c2cb33bc5a62d1db12d5f2225d4adc5bb346ed27073af554cbee5deed4228",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.",
                "category": "company",
                "datetime": 1780995734,
                "headline": "1 Profitable Stock with Exciting Potential and 2 That Underwhelm"
              },
              {
                "id": 140572133,
                "url": "https://finnhub.io/api/news?id=1e43f0c3315f080a701688446336ea4429c270f1692c22c5e883bace10cb6406",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "SOLV",
                "summary": "Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session.",
                "category": "company",
                "datetime": 1780945500,
                "headline": "Top S&P500 movers in Monday's session"
              },
              {
                "id": 140572721,
                "url": "https://finnhub.io/api/news?id=ac249af88351922bc21ddf94a8632793da27afa5665cbebd4c3bcff409a36f4b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "SOLV heads into 2026 balancing AI coding growth, cost savings, tariff pressure and a potential 2027 margin risk tied to its 3M supply deal.",
                "category": "company",
                "datetime": 1780939920,
                "headline": "Solventum Trends for 2026: AI Coding, Tariffs, and Margins"
              },
              {
                "id": 140566317,
                "url": "https://finnhub.io/api/news?id=3b6fc16b6d19a8fd349161587661a664532f9c86aa7e6225bdf22f80a96ef57b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including Solventum (NYSE:SOLV) and its peers.",
                "category": "company",
                "datetime": 1780907390,
                "headline": "Q1 Earnings Roundup: Solventum (NYSE:SOLV) And The Rest Of The Surgical Equipment & Consumables - Diversified Segment"
              },
              {
                "id": 140563924,
                "url": "https://finnhub.io/api/news?id=6f2972e3ab42ef5f7fad1508fd81ca3b91b6fd318faba1d5b334f07cbeb958ec",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "In May 2024, a stockholder class action in Delaware challenged aspects of Solventum’s advance notice and nomination by-laws, which the company later amended before resolving the case as moot and agreeing to pay US$120,000 in attorneys’ fees without admitting wrongdoing. This outcome highlights how investor pressure over governance terms can prompt Solventum to adjust its corporate by-laws while balancing legal risk and cost. We’ll now examine how concerns about AI-driven disruption in...",
                "category": "company",
                "datetime": 1780877732,
                "headline": "Is Solventum’s (SOLV) Governance Tweaks Hinting At How It Will Navigate AI Disruption?"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 6,
            "negative_hits": 0,
            "positive_hits": 0,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0,
            "source_article_count": 15,
            "discarded_article_count": 9
          },
          "sentimentPoints": 2
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 17.5,
        "grade": "較差",
        "items": {
          "bbPoints": 2.4,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 1,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 1,
            "vcp_reason": "跌縮量(近10日4日);站上MA50;Ready=N;Confirm=N",
            "vcp_metrics": {
              "up_days": 5,
              "vol_ref": 2024920,
              "down_days": 4,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 1463700,
              "avg_vol_20": 1531720,
              "avg_vol_30": 2024920,
              "range_pct_10": 0.09910853434714198,
              "range_pct_20": 0.1360775957000524,
              "range_pct_30": 0.1360775957000524,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": false,
              "contraction_ok": false,
              "down_shrink_ok": true,
              "up_expand_days": 1,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.7228433715899888,
              "dist_to_20d_high": 0.08559098537520979,
              "down_shrink_days": 4,
              "breakout_level_20d": 83.42,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.728323673248908
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 0.8
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.1,
            "details": {
              "atrPct": 3.0159937073938123,
              "turnoverUsdM": 94.5620276,
              "liquidityPoints": 0.4,
              "volatilityPoints": 0.7
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.SOLV",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 71.6788,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 1,
              "rsi_score": 1,
              "macd_score": 1.5,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 6,
            "take_profit_price": 80.094,
            "target_multiplier": 1.6,
            "technical_strength": 1.22,
            "take_profit_percent": 5
          },
          "positionPoints": 1.1,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 6.031987414787625,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 92.86,
    "atr": {
      "atr": 2.3006,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 4,
      "atr_pct": 3.02
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "弱勢",
      "score": 4,
      "value": -25.12
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.0847
    },
    "kdj": {
      "d": 57.1,
      "j": 46.2,
      "k": 53.47,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "超賣或超買風險",
      "score": 2,
      "value": 36.99
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": 2230230,
      "recentSlope": 16253,
      "previousSlope": -439190
    },
    "rsi": 48.14,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 74.7744,
      "position": "SAR喺價下",
      "distancePct": 1.97,
      "previousTrend": "上升"
    },
    "ma50": 75.186,
    "macd": {
      "macd": 0.49092746807399124,
      "trend": "中性偏多",
      "signal": 0.6527476410256595,
      "histogram": -0.16182017295166828
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 77.629,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "無力",
      "ratio": 0.82,
      "score": 4,
      "avgVolume": 1507359,
      "currentVolume": 1239670
    },
    "derived": {
      "ma20": 77.526,
      "ma50": 75.186,
      "prevClose": 77.94,
      "avgVolume10": 1386787,
      "avgVolume20": 1507359,
      "changePercent": -2.13,
      "avgVolumeForScore": 1507359
    },
    "ma_cross": {
      "ma20": 77.526,
      "ma50": 75.186,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 77.7625,
      "prevMa50": 75.0396,
      "spreadPct": 3.11,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 73.1334,
      "upper": 81.9186,
      "position": "中間"
    },
    "rsi_short": 21.24,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.82
    }
  }
}

Raw metrics JSON

{
  "close": 76.28,
  "volume": 1239670,
  "changePercent": -2.13
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.